BG
Bellevue Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221M | Sell |
676,367
-91,780
| -12% | -$29.9M | 4.86% | 4 |
|
|
2025
Q1 | $207M | Sell |
768,147
-2,121
| -0.3% | -$573K | 4.65% | 5 |
|
|
2024
Q4 | $181M | Sell |
770,268
-38,827
| -5% | -$9.14M | 3.49% | 11 |
|
|
2024
Q3 | $223M | Sell |
809,095
-110,739
| -12% | -$30.5M | 3.61% | 5 |
|
|
2024
Q2 | $224M | Buy |
919,834
+1,550
| +0.2% | +$377K | 3.63% | 6 |
|
|
2024
Q1 | $137M | Buy |
918,284
+32,966
| +4% | +$4.93M | 2.09% | 14 |
|
|
2023
Q4 | $169M | Sell |
885,318
-9,027
| -1% | -$1.73M | 2.59% | 9 |
|
|
2023
Q3 | $158M | Sell |
894,345
-5,305
| -0.6% | -$940K | 2.55% | 7 |
|
|
2023
Q2 | $171M | Buy |
899,650
+16,400
| +2% | +$3.12M | 2.44% | 9 |
|
|
2023
Q1 | $177M | Sell |
883,250
-37,963
| -4% | -$7.6M | 2.57% | 9 |
|
|
2022
Q4 | $219M | Sell |
921,213
-35,549
| -4% | -$8.45M | 2.91% | 8 |
|
|
2022
Q3 | $192M | Sell |
956,762
-101,424
| -10% | -$20.3M | 2.75% | 5 |
|
|
2022
Q2 | $154M | Sell |
1,058,186
-171,377
| -14% | -$25M | 2.18% | 11 |
|
|
2022
Q1 | $201M | Sell |
1,229,563
-105,577
| -8% | -$17.2M | 2.33% | 9 |
|
|
2021
Q4 | $226M | Sell |
1,335,140
-73,278
| -5% | -$12.4M | 2.33% | 7 |
|
|
2021
Q3 | $266M | Sell |
1,408,418
-140,674
| -9% | -$26.6M | 2.7% | 6 |
|
|
2021
Q2 | $263M | Sell |
1,549,092
-78,022
| -5% | -$13.2M | 2.56% | 6 |
|
|
2021
Q1 | $230M | Buy |
1,627,114
+23,614
| +1% | +$3.33M | 2.43% | 8 |
|
|
2020
Q4 | $208M | Buy |
1,603,500
+43,695
| +3% | +$5.68M | 2.39% | 8 |
|
|
2020
Q3 | $227M | Sell |
1,559,805
-50,260
| -3% | -$7.32M | 3.14% | 7 |
|
|
2020
Q2 | $238M | Sell |
1,610,065
-165,199
| -9% | -$24.5M | 3.37% | 6 |
|
|
2020
Q1 | $193M | Sell |
1,775,264
-89,519
| -5% | -$9.74M | 3.75% | 5 |
|
|
2019
Q4 | $215M | Sell |
1,864,783
-100,289
| -5% | -$11.6M | 3.41% | 6 |
|
|
2019
Q3 | $158M | Buy |
1,965,072
+37,678
| +2% | +$3.03M | 2.94% | 7 |
|
|
2019
Q2 | $140M | Buy |
1,927,394
+1,660,089
| +621% | +$120M | 2.39% | 12 |
|
|
2019
Q1 | $25M | Buy |
267,305
+42,920
| +19% | +$4.01M | 1.37% | 20 |
|
|
2018
Q4 | $16.4M | Buy |
224,385
+4,494
| +2% | +$328K | 1.08% | 27 |
|
|
2018
Q3 | $19.2M | Buy |
219,891
+116,391
| +112% | +$10.2M | 1.22% | 25 |
|
|
2018
Q2 | $10.2M | Buy |
103,500
+81,750
| +376% | +$8.05M | 0.87% | 43 |
|
|
2018
Q1 | $2.59M | Sell |
21,750
-350
| -2% | -$41.7K | 0.26% | 68 |
|
|
2017
Q4 | $2.81M | Sell |
22,100
-53,493
| -71% | -$6.8M | 0.29% | 70 |
|
|
2017
Q3 | $8.88M | Sell |
75,593
-49,436
| -40% | -$5.81M | 0.93% | 40 |
|
|
2017
Q2 | $9.97M | Sell |
125,029
-16,871
| -12% | -$1.35M | 1.18% | 34 |
|
|
2017
Q1 | $7.27M | Buy |
141,900
+117,900
| +491% | +$6.04M | 0.97% | 39 |
|
|
2016
Q4 | $899K | Hold |
24,000
| – | – | 0.18% | 89 |
|
|
2016
Q3 | $1.63M | Hold |
24,000
| – | – | 0.29% | 82 |
|
|
2016
Q2 | $1.33M | Hold |
24,000
| – | – | 0.25% | 89 |
|
|
2016
Q1 | $1.51M | Buy |
+24,000
| New | +$1.51M | 0.27% | 86 |
|